ProMetic receives clearance to start trial of PBI-4050 in metabolic-syndrome-associated diabetes Jan. 29, 2015 No Comments
Tekmira authorized to start phase I trial of RNAi therapeutic for HBV infection Dec. 29, 2014 No Comments
Health Canada clears Immunovaccine to conduct phase II trial of DPX-Survivac Nov. 20, 2014 No Comments
PBI-4050 cleared to commence trials in patients with diabetic kidney disease Nov. 12, 2014 No Comments
FDA and Health Canada permit expanded access administration of Tekmira's TKM-Ebola Sep. 23, 2014 No Comments
Antibe Therapeutics receives Canadian clearance to begin phase I program for ATB-346 June 23, 2014 No Comments
RSS